Showing results (361-370 of 4,868) with videos related to

Sort By:
Pageof 487
Urologic Oncology|June 7, 2021
Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume centerChristoph Würnschimmel, Mike Wenzel, Nuowei Wang, et al.
Urologic Oncology|June 25, 2022
Impact of dedicated renal enhanced recovery after surgery (RERAS) program on postoperative opioid consumption and evaluation of surgeon-specific compliance to the programEmily H Roebuck, Samuel J Ivan, Myra M Robinson, et al.
Urologic Oncology|November 26, 2022
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracersDaniel H Kwon, Nonna Shakhnazaryan, David Shui, et al.
Urologic Oncology|December 18, 2022
Palliative care knowledge, attitudes, and experiences amongst patients with bladder cancer and their caregiversPauline Filippou, Lee A Hugar, Renata Louwers, et al.
Urologic Oncology|December 5, 2022
Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resectionErnest Morton, Sumedh Kaul, Aaron Fleishman, et al.
Urologic Oncology|November 25, 2022
Nephron-sparing surgery for renal cell carcinoma in children and young adults: A systematic reviewAdree Khondker, Jethro C C Kwong, Michael E Chua, et al.
Urologic Oncology|January 11, 2023
Treatment outcomes of postoperative ultra-hypofractionated stereotactic body radiotherapy in prostate cancerGokhan Ozyigit, Cem Onal, Caglayan Selenge Beduk Esen, et al.
Urologic Oncology|January 11, 2023
Does care fragmentation in patients with bladder cancer lead to worse outcomes?Carlos Riveros, Victor Chalfant, Ahmed Elshafei, et al.
Urologic Oncology|January 18, 2023
Actionable genomic landscapes from a real-world cohort of urothelial carcinoma patientsThomas Gerald, Vitaly Margulis, Xiaosong Meng, et al.
Urologic Oncology|January 7, 2023
Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapyCarlos Riveros, Sanjana Ranganathan, Jiaqiong Xu, et al.
Pageof 487